SPDR S&P Biotech shares owned by Clark Capital Management Group
Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Clark Capital Management Group
from 13F filings
Historical chart of Clark Capital Management Group investment in SPDR S&P Biotech
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Biotech held by Clark Capital Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SPDR S&P Biotech by Clark Capital Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $3.1M | 20k | 158.25 |
| 2025-03-31 | $2.9M | 35k | 81.10 |
| 2024-06-30 | $4.3M | 47k | 92.71 |
| 2023-06-30 | $3.4M | 41k | 83.20 |
| 2023-03-31 | $3.1M | 41k | 76.21 |
| 2022-12-31 | $5.5M | 66k | 83.00 |
| 2022-09-30 | $5.1M | 65k | 79.32 |
| 2022-06-30 | $5.2M | 70k | 74.27 |
| 2017-09-30 | $1.3M | 15k | 86.57 |
More positions owned by Clark Capital Management Group
View all positions for Clark Capital Management Group